<DOC>
	<DOCNO>NCT00093223</DOCNO>
	<brief_summary>This trial treat patient new chemotherapeutic medicine undergone successful uncomplicated de novo stent placement two native coronary artery . The purpose trial determine appropriate dose new medicine future trial evaluate incidence treatment-emergent adverse event serious adverse event .</brief_summary>
	<brief_title>A Safety Study ABI-007 In-Stent Restenosis</brief_title>
	<detailed_description>See inclusion/exclusion criterion .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Undergone successful uncomplicated de novo stent placement two native coronary artery Diagnosis angina pectoris At least 18 yr old If female , negative pregnancy test , nonlactating , agree utilize method prevent pregnancy No previous treatment InStent Restenosis Patient agree comply followup evaluation Informed Consent obtain Target vessel least 3 mm diameter Total stent le 25 mm Left ventricular ejection fraction least 30 % No single stent use per lesion No one stented lesion per vessel exception 2 lesion single vessel allowable cover less 25 mm continuous stent By Intravascular Ultrasound ( IVUS ) , stent fully oppose minimum diameter 3 mm instent luminal area least 7 mm2 TIMI 3 coronary flow poststenting No angiographic evidence thrombus poststenting General More two lesion treat Percutaneous Coronary Intervention ( PCI ) anticipate additional lesion require treatment within two month Previous PCI within precede three month Previous participation another study within 30 day Life expectancy le 12 month Factors make followup difficult Intended surgical intervention within 6 month study participation Investigator decision patient unsuitable Recipient heart transplant Q wave nonQ wave Myocardial Infarction ( MI ) document total CK great 2X normal upper limit within precede 24 hrs CK CKMB enzymes remain normal time procedure Cardiogenic shock May refuse blood transfusion Gastrointestinal bleeding within past 3 month Platelet count le 100,000 cells/mm3 Impaired renal function Known allergies/hypersensitivity aspirin , clopidogrel bisulfate , and/or stainless steel Exclusion Criteria Related Angioplasty : Intervention another lesion occur within 90 day plan within 60 day index procedure Stent locate coronary bypass Unprotected leave main disease great 50 % stenosis Lost side branch great 2 mm stenting procedure Angiographic evidence thrombus poststenting Prior stent within 5 mm target lesion Left ventricular ejection fraction le 30 % Greater 50 % stenosis proximal distal target lesion Malposition , dissection , unmask significant narrowing inflow outflow area implant stent Patient receive drug coat stent part procedure Exclusion Criteria Related ABI007 : Absolute neutrophil count less 1500 cells/mm3 Platelet count le 100,000 cells/mm3 Bilirubin great 1.5 mg/dl SGOT SGPT great 2.5X upper limit normal alkaline phosphatase great 2.5X upper limit normal Creatinine great 2.5X upper limit normal Preexisting peripheral neuropathy NCI toxicity Criteria Scale Grade great 1 Immunosuppressed HIV AIDS Hypersensitivity Taxane</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>In-Stent Restenosis</keyword>
</DOC>